George is responsible for the full range of functions required to advance compounds from the preclinical development stage into Phase 1 clinical studies, or to human testing, including pharmaceutical sciences, process chemistry, and preclinical safety. He joined the medicinal chemistry group at Neurogen in 1997 as Senior Research Fellow and assumed several positions of increasing responsibility at the Company, being promoted to Executive Director, Chemistry in 2006.
Before joining Neurogen, George had served as Senior Associate Scientist at Hoechst Marion Roussel Inc., Cincinnati Research Institute, where he was a discovery chemistry project team leader. Prior to obtaining his Ph.D., he worked as a chemist at E.I. Du Pont de Nemours & Co., Experimental Station.
George holds a B.S. degree in chemistry, summa cum laude, from Marietta College, Marietta, Ohio and a PhD in organic chemistry from The Ohio State University, Columbus, Ohio.